Search results
Showing 151 to 165 of 181 results for cognitive behaviour therapy
versus generic CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of specific...
should be tested using an RCT design with standard care (for example, group CBT) as the comparison. It should report short- and...
or lack of efficacy. There is evidence that psychological interventions (CBT and family intervention) as an adjunct to antipsychotic...
clinical and cost effectiveness for family intervention combined with individual CBT in the treatment of children and young people...
Are the psychological interventions [cognitive behavioural therapy] (CBT), hypnotherapy and psychological...
headache disorders:- Does a psychological intervention such as cognitive behavioural therapy (CBT) improve headache...
is the relative effectiveness of sertraline compared with cognitive behavioural therapy (CBT) in people with generalised...
interventions most likely to have an impact is family intervention and individual CBT. The key outcomes should include symptoms, relapse...
symptoms in people with psychosis and schizophrenia:- What is the benefit of a CBT-based trauma reprocessing intervention on PTSD...
Is acupuncture effective in reducing alcohol consumption compared with standard care?
acamprosate or naltrexone) and psychological treatments (for example, cognitive behavioural therapies and social network and...
This quality standard covers reducing and preventing tobacco use in adults, young people and children. It includes interventions to discourage people from taking up smoking, tobacco control strategies and smokefree policies. It is particularly relevant to local authorities, schools and colleges, employers and NHS service providers. It describes high-quality care in priority areas for improvement.
View quality statements for QS82Show all sections
Sections for QS82
- Quality statements
- Quality statement 1: Schools and colleges: interventions
- Quality statement 2: Schools and colleges: smokefree grounds
- Quality statement 3: Underage sales
- Quality statement 4: Workplace policy
- Quality statement 5: Healthcare services: employee contracts
- Quality statement 6: Healthcare settings: smokefree grounds
- Quality statement 7: Healthcare settings: nicotine-containing products and stop-smoking pharmacotherapies
This quality standard covers treating and managing psychosis and schizophrenia in adults (aged 18 and over) in primary, secondary and community care. It also includes support for the families and carers of people with psychosis or schizophrenia. It describes high-quality care in priority areas for improvement.
View quality statements for QS80Show all sections
Sections for QS80
- Quality statements
- Quality statement 1: Referral to early intervention in psychosis services
- Quality statement 2: Cognitive behavioural therapy
- Quality statement 3: Family intervention
- Quality statement 4: Treatment with clozapine
- Quality statement 5: Supported employment programmes
- Quality statement 6: Assessing physical health
- Quality statement 7: Promoting healthy eating, physical activity and smoking cessation
Nalmefene for reducing alcohol consumption in people with alcohol dependence (TA325)
Evidence-based recommendations on nalmefene (Selincro) for reducing alcohol consumption in adults with alcohol dependence.
This guideline covers identifying, assessing and managing alcohol-use disorders (harmful drinking and alcohol dependence) in adults and young people aged 10 to 17 years. It aims to reduce harms (such as liver disease, heart problems, depression and anxiety) from alcohol by improving assessment and setting goals for reducing alcohol consumption.
Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitus (MIB5)
NICE has developed a Medtech Innovation Briefing (MIB) on the Acoustic CR Neuromodulation system